As Of | Group Member | Filings # Latest | With Filer (Primary) | Issuer (Primary) |
---|
| |
---|
2/14/24 | | | Flagship Pioneering Fund VI, L.P. | 7 | SC 13G/A | | Flagship Ventures Fund V, L.P. | | Sana Biotechnology, Inc. |
---|
| | | Flagship Pioneering, Inc. | 7 |
| | | Flagship V Venturelabs RX Fund, L.P. | 4 |
| | | Flagship Venturelabs V, LLC | 4 |
| | | Flagship Ventures Fund V General Partner LLC | 4 |
| | • | Noubar B. Afeyan, Ph. D. | 5 |
| | | Venturelabs V Manager LLC | 4 |
2/27/23 | | | Flagship Pioneering Fund VII General Partner LLC | 2 | SC 13D/A | | Flagship Ventures Fund V, L.P. | | Omega Therapeutics, Inc. |
---|
| | | Flagship Pioneering Fund VII, L.P. | 2 |
| | | Flagship Pioneering Special Opportunities Fd II Gen’l P..LLC | 2 |
| | | Flagship Pioneering Special Opportunities Fund II, L.P. | 2 |
| | | FPN General Partner LLC | 2 |
| | | FPN, L.P. | 2 |
| | | Noubar Afeyan | 2 |
| | | Nutritional Health LTP Fund General Partner LLC | 5 |
| | | Nutritional Health LTP Fund, L.P. | 5 |
7/7/22 | | | Flagship Ventures Fund IV General Partner LLC | 3 | SC 13D/A | | Flagship VentureLabs IV, LLC | | Seres Therapeutics, Inc. |
---|
| | | Flagship Ventures Fund IV, L.P. | 3 |
| | | Flagship Ventures Fund IV – RX, L.P. | 3 |
6/28/19 | | | Edwin M. Kania, Jr. | 1 | SC 13D | | Flagship VentureLabs IV, LLC | | Seres Therapeutics, Inc. |
---|